CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 24 enrolled
Drug / intervention
Quinine Sulfate Capsules 324 mg +1 moredrug
Likely dose
Quinine Sulfate Capsules 324 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00726895
NCT00726895Phase 1Completed
CompareCT.gov

A Randomized, Two-way Crossover Design Used to Compare the Dose Proportionality of Quinine Sulfate Capsules, 324 mg Following a Single Oral Dose of 1 x 324 mg Capsule Versus 2 x 324 mg Capsules in Healthy Adult Volunteers

Mutual Pharmaceutical Company, Inc.·interventional·Posted Aug 1, 2008·Updated Jan 20, 2010

In Brief

A Phase 1 clinical trial evaluating Quinine Sulfate Capsules 324 mg for Healthy. Completed, enrolled 24 participants.

Detailed Summary

The purpose of this study is to evaluate and compare the dose proportionality of 324 mg Quinine Sulfate capsules following a single oral dose (1 x 324 mg capsules versus 2 x 324 mg capsules) in healthy adult volunteers when administered under fasting conditions.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
Countries--
Collaborators--

Timeline

Phase 1CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 1, 2008
Enrollment StartMay 1, 2004
Primary CompletionJun 1, 2004
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 17.9 years ago

Interventions

Quinine Sulfate Capsules 324 mgdrug

1 x 324 mg capsule

Quinine Sulfate Capsules 324 mgdrug

2 x 324 mg capsules